Antiretroviral therapy initiation timing

Exposure

1 paper1 finding

  • 1 lab in 1 country
  • Funders: Gilead Sciences and 7 more
  • Humans1

Outcomes

1

Framingham risk score

no changein humans1

1 study
  1. Antiretroviral therapy initiation timing has no effect on Framingham risk score in humans.

    “However, in matched cohorts, no differences were found in FRS-based outcomes.”

    Humansafter 6 years of ART in age- and gender-matched cohorts6 yearsmatcheds

    Framingham risk score based vascular outcomes in acute versus chronic HIV cohorts after 6 years of ART

    HIV medicine21 Feb 2024

More on Framingham risk score

Latest